Morziul Haque*

Doctor of Pharmacy, University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, India

*Corresponding Author: Morziul Haque, Doctor of Pharmacy, University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, India.

Received: August 06, 2025; Published: August 20, 2025

Abstract

In order to maximize therapeutic interventions, clinical pharmacology has developed into a multidisciplinary subject that combines clinical medicine, molecular science, and regulatory frameworks. Recent developments including pharmacogenomics, AI-driven trials, precision medicine, and the move toward patient-centered treatments are examined in this overview. Obstacles still exist, such as the integration of new technology, global access discrepancies, and drug development constraints. In order to shed light on the present situation and bright future of clinical pharmacology, this literature review systematically synthesizes data from more than 50 original sources. Keywords: Clinical Pharmacology; Precision Medicine; Pharmacogenomics; Drug Development; AI in Healthcare; Translational Medicine; Therapeutic Innovation; Patient-Centered Care

References

1. Cracowski J., et al. “Clinical pharmacology: Current innovations and future challenges”. Fundamental and Clinical Pharmacology 36 (2021): 456-467.
2. Shahin MH., et al. “The patient‐ centered future of clinical pharmacology”. Clinical Pharmacology and Therapeutics 107 (2019).
3. Rieder M. “Clinical pharmacology and the individualized approach to treatment”. In Drug Therapy and Children in LMICs (2015): 187-201.
4. Brouwer K L., et al. “Clinical Pharmacology Education - The Decade Ahead”. Clinical Pharmacology and Therapeutics 107 (2019).
5. Waldman S A and Terzic A. “Clinical Pharmacology and Therapeutics: Past, Present, and Future”. Clinical Pharmacology and Therapeutics 101 (2017).
6. Longuespée R., et al. “Approaching sites of action of drugs in clinical pharmacology: New analytical options and their challenges”. British Journal of Clinical Pharmacology 87 (2020): 858-874.
7. Magavern E and Cremers T. “Introduction to clinical pharmacology at large”. British Journal of Clinical Pharmacology 87 (2021).
8. Castillejos-López MJ., et al. “Contributions of pharmacogenomics to enhance the efficiency of randomized clinical trials”. Revista de Investigación Clínica 5 (2006): 512-524.
9. Sitar D. “The evolving role of the Journal of Clinical Pharmacology and its contributions to the discipline”. Journal of Clinical Pharmacology 53 (2013).
10. Richards D B. “An agenda for UK clinical pharmacology: Developing and delivering clinical pharmacology in pharmaceutical companies”. British Journal of Clinical Pharmacology6 (2012): 870-873.
11. Lee S., et al. “Clinical Pharmacology Considerations in Development of Gastrohepatology Products”. Clinical Pharmacology and Therapeutics 92 (2012).
12. Assil S., et al. “Pharmacological challenge models in clinical drug development”. In Translational Studies on Inflammation (2019).
13. Uhl K. “Advancing women's health in the 21^st century: Applying the tools of clinical pharmacology”. Clinical Pharmacology and Therapeutics 83 (2021).
14. Walker L., et al. “The future of clinical pharmacology in the NHS”. Prescriber 32 (2021).
15. Lacerda D A., et al. “Advances and challenges in the clinical practice of respiratory tract pharmacology and pharmacotherapy”. Revista Sistemática (2024).

Citation

Citation: Morziul Haque. “Advances and Prospects in Clinical Pharmacology: An Extensive Review of the Literature". Acta Scientific Pharmaceutical Sciences 9.9 (2025): 23-27.

Copyright

Copyright: © 2025 Morziul Haque. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.